Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Yoneda

Showing results (71-80 of 454) with videos related to

Pageof 46
Sort By:
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|October 10, 2018
[Gut microbiota and nonalcoholic steatohepatitis]Takaomi Kessoku, Kento Imajo, Takashi Kobayashi, et al.
Expert Opinion on Emerging Drugs|July 16, 2013
Emerging drugs for non-alcoholic steatohepatitisWataru Tomeno, Masato Yoneda, Kento Imajo, et al.
Life (Basel, Switzerland)|November 25, 2023
Frontiers of Collaboration between Primary Care and Specialists in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease: A ReviewKoki Nagai, Kazuki Nagai, Michihiro Iwaki, et al.
Journal of Medical Ultrasonics (2001)|June 10, 2016
Evaluation of hepatocellular carcinoma with portal vein tumor thrombosis by CEUS before and after hepatic arterial infusion chemotherapyHiroyuki Kirikoshi, Satoru Saito, Norio Ueno, et al.
Gastroenterology & Hepatology|April 24, 2015
Effects of statins on the risk of hepatocellular carcinomaPejman G Mansourian, Masato Yoneda, M Krishna Rao, et al.
Hepato-Gastroenterology|October 26, 2011
Sitagliptin as a novel treatment agent for non-alcoholic Fatty liver disease patients with type 2 diabetes mellitusTomoyuki Iwasaki, Masato Yoneda, Masahiko Inamori, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 17, 2025
Utilizing Altmetrics to Track Advancements in Noninvasive Tests for MASLDMasato Yoneda, Yoshio Sumida, Yoshihiro Kamada, et al.
Clinical and Molecular Hepatology|December 12, 2022
Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and futureAsako Nogami, Masato Yoneda, Michihiro Iwaki, et al.
BMC Gastroenterology|June 2, 2022
Two differentially methylated region networks in nonalcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinomaSuguru Kurokawa, Masato Yoneda, Yuji Ogawa, et al.
Diabetes Care|September 28, 2005
Serum ferritin is associated with visceral fat area and subcutaneous fat areaTomoyuki Iwasaki, Atsushi Nakajima, Masato Yoneda, et al.
Pageof 46

Showing results (71-80 of 454) with videos related to

Sort By:
Pageof 46
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|October 10, 2018
[Gut microbiota and nonalcoholic steatohepatitis]Takaomi Kessoku, Kento Imajo, Takashi Kobayashi, et al.
Expert Opinion on Emerging Drugs|July 16, 2013
Emerging drugs for non-alcoholic steatohepatitisWataru Tomeno, Masato Yoneda, Kento Imajo, et al.
Life (Basel, Switzerland)|November 25, 2023
Frontiers of Collaboration between Primary Care and Specialists in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease: A ReviewKoki Nagai, Kazuki Nagai, Michihiro Iwaki, et al.
Journal of Medical Ultrasonics (2001)|June 10, 2016
Evaluation of hepatocellular carcinoma with portal vein tumor thrombosis by CEUS before and after hepatic arterial infusion chemotherapyHiroyuki Kirikoshi, Satoru Saito, Norio Ueno, et al.
Gastroenterology & Hepatology|April 24, 2015
Effects of statins on the risk of hepatocellular carcinomaPejman G Mansourian, Masato Yoneda, M Krishna Rao, et al.
Hepato-Gastroenterology|October 26, 2011
Sitagliptin as a novel treatment agent for non-alcoholic Fatty liver disease patients with type 2 diabetes mellitusTomoyuki Iwasaki, Masato Yoneda, Masahiko Inamori, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 17, 2025
Utilizing Altmetrics to Track Advancements in Noninvasive Tests for MASLDMasato Yoneda, Yoshio Sumida, Yoshihiro Kamada, et al.
Clinical and Molecular Hepatology|December 12, 2022
Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and futureAsako Nogami, Masato Yoneda, Michihiro Iwaki, et al.
BMC Gastroenterology|June 2, 2022
Two differentially methylated region networks in nonalcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinomaSuguru Kurokawa, Masato Yoneda, Yuji Ogawa, et al.
Diabetes Care|September 28, 2005
Serum ferritin is associated with visceral fat area and subcutaneous fat areaTomoyuki Iwasaki, Atsushi Nakajima, Masato Yoneda, et al.
Pageof 46